Table 4.

Correlation between BU PK (initial-dose PK) results and HCT-related complications: Css and tAUC

CssAUC
nTotal, n = 38n = 5n = 11n = 12n = 4Total, n = 38n = 1n = 10n = 19n = 2
Css, ng/mL; AUC, mg/L × h<600600-749.9750-900>900<57.557.5-71.972-86.3>86.3
SOS, n (%) 8 (21) 0 (0) 4 (36) 2 (17) 1 (25) 8 (21) 0 (0) 3 (30) 4 (21) 0 (0) 
Pulmonary complications, n (%) 9 (24) 0 (0) 3 (27) 5 (42) 1 (25) 9 (24) 0 (0) 3 (30) 6 (32) 0 (0) 
 PA hypertension 
 Interstitial pneumonia 
 COP 
 ARDS 
 Pulmonary hemorrhage 
CssAUC
nTotal, n = 38n = 5n = 11n = 12n = 4Total, n = 38n = 1n = 10n = 19n = 2
Css, ng/mL; AUC, mg/L × h<600600-749.9750-900>900<57.557.5-71.972-86.3>86.3
SOS, n (%) 8 (21) 0 (0) 4 (36) 2 (17) 1 (25) 8 (21) 0 (0) 3 (30) 4 (21) 0 (0) 
Pulmonary complications, n (%) 9 (24) 0 (0) 3 (27) 5 (42) 1 (25) 9 (24) 0 (0) 3 (30) 6 (32) 0 (0) 
 PA hypertension 
 Interstitial pneumonia 
 COP 
 ARDS 
 Pulmonary hemorrhage 

ARDS, acute respiratory distress syndrome; COP, cryptogenic organizing pneumonia; PA, pulmonary artery.

or Create an Account

Close Modal
Close Modal